Improved survival of patients with primary plasma cell leukemia with <scp>VRd</scp> or daratumumab‐based quadruplets: A multicenter study by the Greek myeloma study group

MLA

Eirini Katodritou, et al. “Improved Survival of Patients with Primary Plasma Cell Leukemia with VRd or Daratumumab‐based Quadruplets: A Multicenter Study by the Greek Myeloma Study Group.” American Journal of Hematology, vol. 98, Mar. 2023, pp. 730–38. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f9380d9ded7c86334e0b5ffda266fcdc&authtype=sso&custid=ns315887.

APA

Eirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, Sosana Delimpasi, Emmanouil Spanoudakis, Vasiliki Labropoulou, Ioannis Ntanasis‐Stathopoulos, Annita‐Ioanna Gkioka, Nikos Giannakoulas, Nikolaos Kanellias, Theodosia Papadopoulou, Aggeliki Sevastoudi, Eyrydiki Michalis, Maria Papathanasiou, Maria Kotsopoulou, Anastasia Sioni, Theodora Triantafyllou, Aikaterini Daiou, Mavra Papadatou, … Evangelos Terpos. (2023). Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab‐based quadruplets: A multicenter study by the Greek myeloma study group. American Journal of Hematology, 98, 730–738.

Chicago

Eirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, Sosana Delimpasi, Emmanouil Spanoudakis, Vasiliki Labropoulou, Ioannis Ntanasis‐Stathopoulos, et al. 2023. “Improved Survival of Patients with Primary Plasma Cell Leukemia with VRd or Daratumumab‐based Quadruplets: A Multicenter Study by the Greek Myeloma Study Group.” American Journal of Hematology 98 (March): 730–38. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........f9380d9ded7c86334e0b5ffda266fcdc&authtype=sso&custid=ns315887.